10,309 Shares in The Allstate Co. (NYSE:ALL) Acquired by Versor Investments LP

Versor Investments LP bought a new position in The Allstate Co. (NYSE:ALL - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,309 shares of the insurance provider's stock, valued at approximately $1,955,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. GDS Wealth Management lifted its holdings in shares of Allstate by 6.3% during the third quarter. GDS Wealth Management now owns 85,962 shares of the insurance provider's stock valued at $16,303,000 after acquiring an additional 5,121 shares during the period. Kennebec Savings Bank bought a new position in Allstate during the 3rd quarter valued at about $606,000. Ashton Thomas Securities LLC acquired a new position in Allstate in the third quarter valued at about $228,000. Los Angeles Capital Management LLC grew its stake in Allstate by 688.4% during the third quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider's stock worth $87,292,000 after buying an additional 401,901 shares during the last quarter. Finally, TimesSquare Capital Management LLC acquired a new stake in shares of Allstate during the third quarter worth approximately $77,819,000. Institutional investors own 76.47% of the company's stock.

Insider Activity at Allstate

In other news, EVP Elizabeth Brady sold 49,481 shares of Allstate stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the sale, the executive vice president now directly owns 19,163 shares in the company, valued at $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider John E. Dugenske sold 36,367 shares of the firm's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares of the company's stock, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares of the company's stock, valued at approximately $3,431,901.67. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 192,530 shares of company stock valued at $34,967,665. 1.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ALL shares. JPMorgan Chase & Co. boosted their price objective on Allstate from $205.00 to $207.00 and gave the stock an "overweight" rating in a research note on Thursday, October 10th. Keefe, Bruyette & Woods raised their price target on shares of Allstate from $222.00 to $225.00 and gave the company an "outperform" rating in a report on Wednesday, November 6th. Raymond James increased their price objective on Allstate from $205.00 to $220.00 and gave the company a "strong-buy" rating in a research report on Friday, October 4th. Piper Sandler upped their price target on Allstate from $188.00 to $196.00 and gave the company an "overweight" rating in a research note on Friday, August 16th. Finally, Morgan Stanley lifted their price objective on Allstate from $220.00 to $228.00 and gave the stock an "overweight" rating in a research report on Thursday. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $212.56.

Allstate Stock Up 0.3 %

NYSE ALL traded up $0.62 during trading hours on Monday, reaching $197.52. 1,251,868 shares of the company's stock were exchanged, compared to its average volume of 1,556,289. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The company has a market capitalization of $52.30 billion, a price-to-earnings ratio of 12.79, a price-to-earnings-growth ratio of 1.83 and a beta of 0.48. The company's 50-day moving average is $189.09 and its two-hundred day moving average is $175.87. The Allstate Co. has a one year low of $129.17 and a one year high of $201.00.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts' consensus estimates of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same period last year, the business posted $0.81 earnings per share. The firm's quarterly revenue was up 14.7% on a year-over-year basis. On average, analysts forecast that The Allstate Co. will post 15.32 EPS for the current fiscal year.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.